Zevra Therapeutics, Inc. (ZVRA)
NASDAQ·Healthcare·Biotechnology
$12.02
-0.41%
Mkt Cap $712.93M
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (19 analysts)
$25.75
Range $20.00 – $35.00
Implied Upside
+114.3%
Consensus $25.75 vs current $12.02
NASDAQ·Healthcare·Biotechnology
$12.02
-0.41%
Mkt Cap $712.93M
Buy
13
Hold
0
Sell
0
Price Target (19 analysts)
$25.75
Range $20.00 – $35.00
+114.3%
Consensus $25.75 vs current $12.02